More than 60 judges on SBANE’s panel sifted through 200 organizations to name 20 finalists and eight winners. The New England Innovation Awards honored Histogenics as a top local company for product innovation and research in cartilage repair. SBANE seeks to recognize innovative companies that deliver proven value to customers.
“The recognition by the judges of the valuable work our local employees are doing to provide patient and physicians better alternatives to repair cartilage defects is especially rewarding,” said President and CEO of Histogenics Adam Gridley.
The company’s NeoCart, designed to treat knee cartilage defects, is in Phase III clinical trials.
More articles on orthopedic devices:
Alphatec revenue drops 19.8% in Q1: 5 things to know
Device executive pleads guilty to stealing company secrets and plans—5 key details
Coventus Orthopaedics raises $20M to fund Cage repair therapy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.